Welcome.
Are you a healthcare professional?

This website contains promotional information for Chiesi's respiratory products, and is intended solely for UK healthcare professionals. Please confirm below, or go back to the home page.

UK-RES-2000248 Feb 2020

You are now leaving Chiesi's website

By clicking this link, you will be taken to a website that is not owned or controlled by Chiesi. Chiesi is not responsible for the content provided on that site.

Continue
Go back

UK-RES-2000003 Jan 2020

INTENDED FOR UK HEALTHCARE PROFESSIONALS
Atimos® Formoterol pMDI logo
Background
Atimos® Formoterol pMDI logo with device

Asthma: Licensed in adults and adolescents 12 years and above
COPD: Licensed in adults 18 years and above

Asthma: Licensed in adults and
adolescents 12 years and above
COPD: Licensed in adults 18 years and above

Asthma: Licensed in adults and adolescents 12 years and above
COPD: Licensed in adults 18 years and above

What is Atimos®?

Atimos is available in a pressurised metered-dose inhaler (pMDI), delivering 100 inhalations of 12 micrograms of formoterol fumarate dihydrate per device.

Indications for Atimos1

Asthma
For the long-term symptomatic treatment of persistent, moderate to severe asthma in patients requiring regular bronchodilator therapy in combination with long-term anti-inflammatory therapy (inhaled and/or oral glucocorticoids).

Glucocorticoid therapy should be continued on a regular basis.

COPD
Atimos is indicated for the relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease (COPD).

Atimos® Modulite® pMDI Device
For additional information to share with your patients who have been prescribed Atimos please visit our Atimos patient and carer site.
Reference:
1. Atimos Summary of Product Characteristics. Chiesi Limited.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.